Zota Health Care LImited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Manukant C. Zota, was filed 01 Jul 2021.
Who traded when
BuySaleSince the insiders bought
- +23.7%Entry ₹218.50 · Close at T+365 ₹270.20
- +23.7%Entry ₹218.50 · Close at T+365 ₹270.20
- +23.7%Entry ₹218.50 · Close at T+365 ₹270.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 2,000 shares@ ₹1,461.524532.5% of flowEquity SharesSEBI:ab51953211281c2e4ad8ac50e2db7ba8eb792c4f
- 14,734 shares@ ₹381.7554.1% of flowEquity SharesSEBI:47fe5071592637148b6344c7c8bb3e1dfbfe9dfc
- 10,000 shares@ ₹936.1557.0% of flowEquity SharesSEBI:7c45748f0dc4596ae23e5dce2ce878c6befdec06
- 97,200 shares@ ₹774.6674100.0% of flowEquity SharesSEBI:a79db5414ade79549315d61a5151ddef34b7a6a3
- 95,000 shares@ ₹774.4513100.0% of flowEquity SharesSEBI:7861455c46c0cbd8aa97631ce3aabc99173de1c9
- 2,000 shares@ ₹780.6120.4% of flowEquity SharesSEBI:b26d5ba894709f9c854baf5e8f6723efd2358af0
- 6,072 shares@ ₹608.5075.6% of flowEquity SharesSEBI:e90d6782d83361b2e4a98db41eeabec2e4fccd4f
- 6,072 shares@ ₹608.5047.1% of flowEquity SharesSEBI:4f3a2bb318d1c81c3e1863676678e5523442b614
- 10,000 shares@ ₹657.50100.0% of flowEquity SharesSEBI:aaaf1e87bf345034dc3280c62c7ca0f540270254
- 10,000 shares@ ₹657.5043.0% of flowEquity SharesSEBI:3fd89247c7198b325dcf23f7530da9068ba94730
- 4,912 shares@ ₹509.0026.3% of flowEquity SharesSEBI:96250b4f8188c6e5a38de6f1cd34920d57523d8e
- 14,734 shares@ ₹127.2519.7% of flowWarrantsSEBI:3fbf3f1983083a55dba4f90c02fa17c036751282
- 2,181 shares@ ₹521.6075100.0% of flowEquity SharesSEBI:64b712cb973197161225b4f4b6ea9a23589bac11
- 40,000 shares@ ₹375.80100.0% of flowEquity SharesSEBI:7e9e00e97c83f4d5e76997468a0ce7c30da60488
- 21,500 shares@ ₹288.2546.3% of flowEquity SharesSEBI:1f512730f980df62a6cfc94778b1ac6f08f52c7f
- 21,500 shares@ ₹288.25100.0% of flowEquity SharesSEBI:7e000dff2e9261533c952da61ce58340765fcfe2
- 23,000 shares@ ₹262.45100.0% of flowEquity SharesSEBI:c9f8b9028d61bef60966d0224ebf14d07bfd9045
- 23,000 shares@ ₹262.4545.9% of flowEquity SharesSEBI:90a4304bc84542e6305aaed877b3692745205126
- 3,000 shares@ ₹381.3324.4% of flowEquity SharesSEBI:27be932c92c6126b82d8cc8992e4a4ded80bec0e
- 3,360 shares@ ₹356.20240.0039% mcap100.0% of flowEquity SharesSEBI:972de786e835bd9f663149bc563c71a819ec8428
- 5,238 shares@ ₹314.95270.0054% mcap100.0% of flowEquity SharesSEBI:4648f976366a9aac1d07922131c718c3ade71cdd
- 8,000 shares@ ₹300.15090.0078% mcap100.0% of flowEquity SharesSEBI:3e8ae83c407a4b4e88d9b1478156bb4923360566
- 8,030 shares@ ₹263.000.0069% mcap100.0% of flowEquity SharesSEBI:a35401ef6382b05194255b322c398fceec0f0801
- 13,500 shares@ ₹270.260.012% mcap100.0% of flowEquity SharesSEBI:0b14cbbd1b36899856fcfc03d55355bfe9207d96
- 18,000 shares@ ₹263.000.015% mcap100.0% of flowEquity SharesSEBI:0338207dffb1d76461a6d6747a38ce7a8c4d49b9
25 of 30 declarations
About Zota Health Care LImited
At Zota Health Care Limited (health care, Bombay Stock Exchange), the record is dominated by sales: 12 sales worth EUR 451,113 (median EUR 25,542) against 4 purchases worth EUR 46,949 (median EUR 11,836), which is 25% purchases among open-market trades. The 4 purchases date from June 30, 2021 and were made by 4 filers; the three largest are EUR 14,051 for Ketankumar Chandulal Zota, EUR 11,883 for Manukant C. Zota and EUR 11,789 for Himnashu Muktilal Zota.
The largest sale, EUR 168,373, is Dhara Ketan Zota's on June 30, 2023. On August 2, 2021, Zota Ketankumar Chandulal (HUF) sold EUR 53,584 and Rasilaben Manukantbhai Zota EUR 41,297. Vinodchandra Dhirajlal Mehta, Promoter Group, has 3 filings, 2 of them sales.
Read moreShow less
Of 30 filings, 12 date from 2021, 8 from 2024, 5 from 2025, 3 from 2023 and 2 from 2022. 14 are of a kind other than purchase or sale. The 22 insiders are on file for a company with a market capitalisation of INR 47.1 billion, and median publication delay is 3 days. No filing falls in the last twelve months.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
